Cargando…

Mood Disorders and Substance Use Disorder: A Complex Comorbidity

Mood disorders, including depression and bipolar disorders, are the most common psychiatric comorbidities among patients with substance use disorders. Treating patients’ co-occurring mood disorders may reduce their substance craving and taking and enhance their overall outcomes. A methodical, staged...

Descripción completa

Detalles Bibliográficos
Autores principales: Quello, Susan B., Brady, Kathleen T., Sonne, Susan C.
Formato: Texto
Lenguaje:English
Publicado: National Institute on Drug Abuse 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851027/
https://www.ncbi.nlm.nih.gov/pubmed/18552741
_version_ 1782179839317377024
author Quello, Susan B.
Brady, Kathleen T.
Sonne, Susan C.
author_facet Quello, Susan B.
Brady, Kathleen T.
Sonne, Susan C.
author_sort Quello, Susan B.
collection PubMed
description Mood disorders, including depression and bipolar disorders, are the most common psychiatric comorbidities among patients with substance use disorders. Treating patients’ co-occurring mood disorders may reduce their substance craving and taking and enhance their overall outcomes. A methodical, staged screening and assessment can ease the diagnostic challenge of distinguishing symptoms of affective disorders from manifestations of substance intoxication and withdrawal. Treatment should maximize the use of psychotherapeutic interventions and give first consideration to medications proven effective in the context of co-occurring substance abuse. Expanded communication and collaboration between substance abuse and mental health providers is crucial to improving outcomes for patients with these complex, difficult co-occurring disorders.
format Text
id pubmed-2851027
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher National Institute on Drug Abuse
record_format MEDLINE/PubMed
spelling pubmed-28510272010-10-25 Mood Disorders and Substance Use Disorder: A Complex Comorbidity Quello, Susan B. Brady, Kathleen T. Sonne, Susan C. Sci Pract Perspect Research Review Mood disorders, including depression and bipolar disorders, are the most common psychiatric comorbidities among patients with substance use disorders. Treating patients’ co-occurring mood disorders may reduce their substance craving and taking and enhance their overall outcomes. A methodical, staged screening and assessment can ease the diagnostic challenge of distinguishing symptoms of affective disorders from manifestations of substance intoxication and withdrawal. Treatment should maximize the use of psychotherapeutic interventions and give first consideration to medications proven effective in the context of co-occurring substance abuse. Expanded communication and collaboration between substance abuse and mental health providers is crucial to improving outcomes for patients with these complex, difficult co-occurring disorders. National Institute on Drug Abuse 2005-12 /pmc/articles/PMC2851027/ /pubmed/18552741 Text en
spellingShingle Research Review
Quello, Susan B.
Brady, Kathleen T.
Sonne, Susan C.
Mood Disorders and Substance Use Disorder: A Complex Comorbidity
title Mood Disorders and Substance Use Disorder: A Complex Comorbidity
title_full Mood Disorders and Substance Use Disorder: A Complex Comorbidity
title_fullStr Mood Disorders and Substance Use Disorder: A Complex Comorbidity
title_full_unstemmed Mood Disorders and Substance Use Disorder: A Complex Comorbidity
title_short Mood Disorders and Substance Use Disorder: A Complex Comorbidity
title_sort mood disorders and substance use disorder: a complex comorbidity
topic Research Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851027/
https://www.ncbi.nlm.nih.gov/pubmed/18552741
work_keys_str_mv AT quellosusanb mooddisordersandsubstanceusedisorderacomplexcomorbidity
AT bradykathleent mooddisordersandsubstanceusedisorderacomplexcomorbidity
AT sonnesusanc mooddisordersandsubstanceusedisorderacomplexcomorbidity